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ABSTRACT
Rosai-Dorfman disease, previously known as sinus histiocytosis with massive lymphadenopathy (SHML) is one of the rare 
benign idiopathic proliferative diseases of phagocytic histiocytes. Majority of the patients present with painless massive cervical 
lymphadenopathy but intrathoracic involvement is rarely reported. Here, we report the case of a 57-year-old male with a history of 
chest pain, shortness of breath and generalized weakness of two-month duration. The diagnosis was formed by core biopsy of the 
axillary lymph node with typical emperipolesis and Immunohistochemistry markers. 
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Destombes-Rosai-Dorfman disease (DRDD) also called as Rosai-Dorfman disease (RDD) is a rare disease first described by Destombes in 1965 and then by Rosai 
and Dorfman in 1969, who captioned it sinus histiocytosis with 
massive lymphadenopathy [1]. It predominantly affects children 
and young adults, commonly males. Most of the patients present 
with painless cervical lymphadenopathy with varying size. Few 
authors have reported the size of the lymph node as big as six 
centimeters leading to respiratory compromise [2]. The usual 
sites of extra-nodal manifestation are soft tissue of head and 
neck, paranasal sinuses and nasal cavity seen in up to 43% of 
patients, while the intra-thoracic involvement is rare and is seen 
in about 2% of cases [3]. Due to difficulty in diagnosis, thoracic 
manifestations of RDD have been reported sporadically in the 
literature. Here, we report a case of Rosai-Dorfman disease with 
intrathoracic manifestation. 
CASE REPORT 
A 57-year-old, diabetic male presented with a history of on and 
off low-grade fever, chest pain, shortness of breath, abdominal 
distention, generalized weakness and significant weight loss of 
2 months duration. He was a non-alcoholic but a chronic smoker 
for more than 20 pack years.
On physical examination, the patient was febrile (axillary 
temperature-100 F), sinus tachycardia with a pulse of 110 beats/
min and oxygen saturation was 88% at room air. There was 
facial puffiness and bilateral axillary lymph nodes were palpable. 
On auscultation of the chest, breath sound was reduced bilaterally, 
more reduced on the right side. Abdominal examination showed a 
distended abdomen with moderate ascites. 
Laboratory investigations revealed normal blood and 
biochemical reports. Chest X-ray showed cardiomegaly, 
Figure 1: Chest X-ray showing cardiomegaly, mediastinal widening 
and bilateral pleural effusion
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mediastinal widening, and bilateral pleural effusion as shown in 
Figure 1. High-resolution computed tomography (HRCT) chest 
revealed pericardial effusion, large necrotic anterior mediastinal 
lymph nodes along with paratracheal and multiple axillary 
lymphadenopathies with vascular encasement likely lymphoma 
or thymoma. Pericardiocentesis to aspirate pericardial fluid was 
performed. The aspirate mainly showed red blood cells along 
with hemosiderin laden macrophages. Abdominal ultrasound 
showed chronic liver disease with moderate ascites. Ascitic 
fluid tapping was done, which showed no malignant cells. 
Pulmonary function test revealed severe obstruction (FEV1/
FVC ratio=19%). 
Axillary lymph node biopsy showed mild nodal architectural 
distortion with thick capsule and expanded sinus filed with 
distinct histiocytes with emperipolesis noted, consistent with 
sinus histiocytosis with lymphadenopathy (Destombes-Rosai-
Dorfman Disease). Immunohistochemistry revealed histocytes 
expressing CD68 and S100 protein. Bone marrow aspiration 
and biopsy revealed hypoplastic marrow with trilineage 
hemopoiesis, adequate megakaryocytic and no evidence of 
granuloma, parasites and malignant cells. FIP1L1-PDGFRa 
Fusion Assay (Qualitative) by reverse transcriptase-polymerase 
chain reaction (RT-PCR) and gel electrophoresis was tested 
which was negative. Hence, a diagnosis of Destombes-Rosai-
Dorfman disease was established.
Short term steroid (Prednisolone 1mg/kg per day for four 
weeks) regimen was initiated and was planned for six cycles of 
CVP (Cyclophosphamide, Vincristine and Prednisolone) based 
chemotherapy. After four cycles of the chemotherapy treatment, 
there was a subsequent improvement of the condition but the 
patient defaulted treatment and lost to follow-up.
DISCUSSION 
Rosai-Dorfman disease is usually a benign condition which 
clinically manifests with low-grade fever, bilateral cervical 
painless lymphadenopathy and generalized weakness which was 
also seen in our case. In the present case, along with the usual 
symptoms, intrathoracic manifestations like chest pain, shortness 
of breath were present. Radiologically, intrathoracic involvement 
includes mediastinal widening along with multiple large necrotic 
lymph nodes.
The differential diagnosis of RDD with intrathoracic 
involvement includes primary mediastinal lymphoma, thymoma, 
lung cancer, sarcoidosis, Wegener’s granulomatosis and 
infectious processes including tuberculosis [4]. The clinical 
features along with histopathological findings, particularly, 
features of ‘emperipolesis’ [5,6] (ie. lymphatic sinuses occupied 
by numerous lymphocytes and histiocytes with vesicular nucleus 
and abundant clear cytoplasm with phagocytized lymphocytes, 
neutrophils or plasma cells) and immunohistochemistry showing 
the cells positive for protein S-100, α-1-antitrypsin and pan-
macrophage antigens (CD68 and HAM56), and negative CD1a7, 
aid in forming the diagnosis of RDD. Our case was also diagnosed 
on the basis of clinical features and histopathology of the biopsy 
taken from the lymph node.
There is no specific laboratory test to establish the diagnosis 
of RDD [7], similarly, in our case the blood and biochemical 
reports were normal, serological tests were negative for 
hepatitis B, hepatitis C and HIV, blood and sputum culture 
were also negative for Klebsiella and Brucella. The pleural 
and ascitic fluid analysis showed normal adenosine deaminase 
(ADA) level with no features of tuberculosis. Bone marrow 
aspiration flow cytometry showed a few scattered reactive 
T-cell component. Immunoglobulin level was not tested in the 
present study.
The differential cytological diagnosis includes 
Haemophagocytic syndrome, Langerhans cell histiocytosis, 
reactive lymph node hyperplasia, and lymphoma. In the 
haemophagocytic syndrome, phagocytosis of the red cell 
by histiocytes is seen while Langerhans cell histiocytes 
have grooved and twisted nuclei with cd1a positivity. The 
reactive lymphadenopathy does not show emperipolesis and 
immunohistochemistry shows negative S-100 while Hodgkin 
lymphoma typically shows Reed-Sternberg cells [8,9]. 
The pathogenesis of RDD is poorly understood although 
many authors suggest its association with infection and 
immunodeficiency [10,11,12]. Viral infections such as Epstein-
Barr virus, parvovirus B19, herpes virus type 6, polyomavirus, 
Klebsiella, Brucella, and cytomegalovirus have been suspected 
as the cause but not clearly linked. The other mechanism 
includes immune dysfunction or an aberrant exaggerated 
immune response to an infectious agent or an antigen that causes 
a proliferation of histiocytes.
Many cases of RDD show spontaneous regression [13]. 
Hence, observation is reasonable, while in some cases, disease 
progression is seen which requires treatment to prevent major 
organs dysfunction. The intrathoracic manifestation of RDD is 
rare and includes mediastinal lymphadenopathy, tracheobronchial 
disease, pleural effusion, cystic and interstitial lung disease [14] 
which was also seen in our case. It results in significant morbidity 
and reported mortality of 45% [15], hence necessitating upfront 
treatment to prevent organ dysfunction.
There are some reports of successful treatment of Rosai 
Dorfman disease with a combination of chemotherapy such as 
alkylating agents and vinca alkaloid with prednisone [16] which 
were also used in our treatment protocol (CVP regimen). There 
are reports of systemic non-Langerhans cell histiocytosis being 
treated successfully with target therapy [17] by Imatinib for c-kit 
and PDGFR positive cases. Our case was evaluated for the same but 
was found to be negative. In refractory cases, analysis of NRAS, 
KRAS, HRAS, MAP2K1, BRAF and ARAF mutations in the 
lesional tissue has been suggested for the use of targeted therapies 
[15]. Recently, on 16th October 2016, the Rare Histiocytosis 
Steering Committee and Working group of Histiocyte Society 
during its 32nd Annual Meeting in Dublin, Ireland, made the first 
consensus multidisciplinary recommendation for the diagnosis 
and management of RDD.[15]
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CONCLUSION
Rosai-Dorfman Disease with intrathoracic involvement may 
manifest as pulmonary nodules with mediastinal lymphadenopathy 
which might be difficult to diagnose and differentiate from other 
similar pathologies. Clinicians should be aware of this rare entity. 
A good pathological laboratory facility is essential to diagnose 
this condition. Although benign in nature, treatment with 
chemotherapy is the modality of treatment.
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